Literature DB >> 6643429

Isolation and characterization of a mannan-binding protein from human serum.

N Kawasaki, T Kawasaki, I Yamashina.   

Abstract

A serum lectin specific for mannose and N-acetylglucosamine residues was isolated from human serum to near homogeneity mainly by affinity chromatography on a column of Sepharose 4B-mannan. The lectin, called mannan-binding protein, was a glycine-rich protein with an apparent molecular size of approximately 600,000 daltons, and had a subunit structure consisting of a single component with an apparent molecular weight of 31,000. Binding of the isolated lectin to 125I-labeled mannan was dependent upon the presence of Ca2+, proportional to the protein added, and a reversible and saturable process. Scatchard plot analysis of binding data indicated the presence of a binding site with a dissociation constant of 2.3 X 10(-9) M and a maximum capacity of 4.3 pmol of 125I-labeled mannan per microgram of protein (2.6 mol of mannan per mol of the protein). The mannan-binding protein, is different from C-reactive protein (CRP) and amyloid P-component (SAP), both of which are serum components known to bind polysaccharides in the presence of Ca2+. A distinct binding activity toward mannan which did not require Ca2+ was attributed to immunoglobulins (IgG).

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6643429     DOI: 10.1093/oxfordjournals.jbchem.a134437

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  51 in total

Review 1.  Complement activation, regulation, and molecular basis for complement-related diseases.

Authors:  Goran Bajic; Søren E Degn; Steffen Thiel; Gregers R Andersen
Journal:  EMBO J       Date:  2015-10-21       Impact factor: 11.598

2.  Neoglycolipids as probes of oligosaccharide recognition by recombinant and natural mannose-binding proteins of the rat and man.

Authors:  R A Childs; K Drickamer; T Kawasaki; S Thiel; T Mizuochi; T Feizi
Journal:  Biochem J       Date:  1989-08-15       Impact factor: 3.857

3.  Induction of platelet-activating factor in mice by intravenous administration of a neutral fraction of bakers' yeast mannan.

Authors:  T Mikami; K Fukushi; M Ishitani; K Ishitani; S Suzuki; M Suzuki
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

4.  Calcium-independent haemolysis via the lectin pathway of complement activation in the guinea-pig and other species*.

Authors:  Y Zhang; C Suankratay; X Zhang; D R Jones; T F Lint; H Gewurz
Journal:  Immunology       Date:  1999-08       Impact factor: 7.397

5.  Pharmacological inhibition of mannose-binding lectin ameliorates neurobehavioral dysfunction following experimental traumatic brain injury.

Authors:  Daiana De Blasio; Stefano Fumagalli; Luca Longhi; Franca Orsini; Alessandro Palmioli; Matteo Stravalaci; Gloria Vegliante; Elisa R Zanier; Anna Bernardi; Marco Gobbi; Maria-Grazia De Simoni
Journal:  J Cereb Blood Flow Metab       Date:  2016-07-20       Impact factor: 6.200

6.  Complement-dependent cytotoxic activity of serum mannan-binding protein towards mammalian cells with surface-exposed high-mannose type glycans.

Authors:  M Ohta; T Kawasaki
Journal:  Glycoconj J       Date:  1994-08       Impact factor: 2.916

7.  Binding of mannose-binding protein to Klebsiella O3 lipopolysaccharide possessing the mannose homopolysaccharide as the O-specific polysaccharide and its relation to complement activation.

Authors:  G Z Jiang; T Sugiyama; Y Kato; N Koide; T Yokochi
Journal:  Infect Immun       Date:  1995-07       Impact factor: 3.441

8.  Chicken mannose-binding lectin (MBL) gene variants with influence on MBL serum concentrations.

Authors:  Rikke M Kjærup; Liselotte R Norup; Karsten Skjødt; Tina S Dalgaard; Helle R Juul-Madsen
Journal:  Immunogenetics       Date:  2013-03-02       Impact factor: 2.846

9.  Immunohistochemical investigation of the tissue distribution of mannan-binding lectin in non-infected and virus-infected chickens.

Authors:  O L Nielsen; P H Jørgensen; J Hedemand; J C Jensenius; C Koch; S B Laursen
Journal:  Immunology       Date:  1998-05       Impact factor: 7.397

10.  Recombinant bovine conglutinin, lacking the N-terminal and collagenous domains, has less conglutination activity but is able to inhibit haemagglutination by influenza A virus.

Authors:  S Eda; Y Suzuki; T Kase; T Kawai; K Ohtani; T Sakamoto; T Kurimura; N Wakamiya
Journal:  Biochem J       Date:  1996-05-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.